A novel minimal residual disease model of neuroblastoma in mice-Reference-Cited by-同舟云学术

A novel minimal residual disease model of neuroblastoma in mice

Published:2016-06 Issue:6 Volume:51 Page:991-994
ISSN:0022-3468
Container-title:Journal of Pediatric Surgery
language:en
Short-container-title:Journal of Pediatric Surgery

Author:

Jackson Jeremy R.,Kim Youngleem,Seeger Robert C.,Kim Eugene S.

Publisher

Elsevier BV

Subject

General Medicine,Pediatrics, Perinatology and Child Health,Surgery

Reference14 articles.

1. Neuroblastoma;Maris;Lancet,2007

2. Neuroblastoma: biology, prognosis, and treatment;Park;Hematol Oncol Clin North Am,2010

3. Recent advances in neuroblastoma;Maris;N Engl J Med,2010

4. In vitro and in vivo preclinical chemotherapy studies of human neuroblastoma;Siegel;Cancer Treat Rep,1980

5. Preclinical models of pediatric solid tumors (neuroblastoma) and their use in drug discovery. In: Enna SJ, Williams M, Barret JF, Ferkany JW, Kenakin T, Porsolt RD, editors. Curr. Protoc. Pharmacol;Patterson,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential RNA Expression Between Metastatic and Primary Neuroblastoma Cells;Journal of Surgical Research;2024-06

2. Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma;Scientific Reports;2023-11-14

3. Anti-relapse effect of trametinib on a local minimal residual disease neuroblastoma mouse model;Journal of Pediatric Surgery;2021-07

4. Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice;Journal for ImmunoTherapy of Cancer;2020-12

Advances in the Detection Technologies and Clinical Applications of Circulating Tumor DNA in Metastatic Breast Cancer

;Cancer Management and Research;2020-05